Welcome to Syncona
Syncona is a unique investment company seeking to deliver transformational treatments to patients. We do this by creating ambitious companies capable of taking their product to market.
We are aligned with two of the premium charitable funders in life science, the Wellcome Trust, original founder of Syncona’s life science division, and Cancer Research UK both of which are significant shareholders in Syncona. We are listed on the London Stock Exchange under the ticker SYNC.